A New Approach to the Treatment of Metastatic Paraganglioma: Sorafenib
Paragangliomas are relatively rare chromaffin cell tumors which may be cured through resection. Patients with paragangliomas may develop metastatic diseases. There is no consensus regarding refractory chemotherapy for treatment of metastatic disease. In this report, we presented a case of a 43-year-...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Korean Cancer Association
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206070/ |